VRCTC-310

N/A

Report date: 2023/05/22 10:16:31

Base Information

Drug NameVRCTC-310
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVentech Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeltic Biotech Iowa Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A